Insights - Syenza

At Syenza, we understand the challenges of finding credible and reliable reviews on important themes impacting innovative healthcare technologies. That’s why we provide in-depth discussions on defined themes that shape our clients’ activities and the support we provide. All our Insight Articles are carefully researched, fully-referenced, updated frequently, and available at no cost on our website. You are welcome to use our work, but please give credit where credit is due.

Rethinking Employer Health Costs for Sustainable Access

August 24, 2026

Rethinking Employer Health Costs for Sustainable Access

Sustained growth in employer health costs is no longer a narrow benefits issue.…

SINACC Access Reform: What the Delay Signals for Market Access

August 17, 2026

SINACC Access Reform: What the Delay Signals for Market Access

Portugal's SINACC Access Reform, built around the Sistema Nacional de Acesso a Consulta…

PRIME Scheme and the SME Gap: What July 2026’s Outcomes Reveal

August 10, 2026

PRIME Scheme and the SME Gap: What July 2026’s Outcomes Reveal

The European Medicines Agency published its latest recommendations on PRIME scheme SME eligibility…

EMA-EFPIA Ninth Bilateral Meeting: Europe’s Pharmaceutical Access Crisis and the Road to Reform

August 3, 2026

EMA-EFPIA Ninth Bilateral Meeting: Europe’s Pharmaceutical Access Crisis and the Road to Reform

On 16 September 2026, the European Medicines Agency (EMA) and the European Federation…

MFN Pricing Readiness When Patients Pay for Delay

July 27, 2026

MFN Pricing Readiness When Patients Pay for Delay

Most Favoured Nation rules often centre on rebates and reference pricing, yet patients…

Oncology Market Access Shapes Sustainable European Innovation

July 20, 2026

Oncology Market Access Shapes Sustainable European Innovation

Oncology market access in Europe now demands a more strategic lens. Recent reflections…